Synthesis and anti-HIV activity evaluation of 2-(5-(naphthalen-1-yl)-1,2,3-thiadiazol-4-ylthio)-N-acetamides derivatives

Latin American Journal of Pharmacy

Volumn 31, Issue 5, 2012, Pages 751-755

  Jiang, Xiaofei ^a,b   Zhan, Peng ^a   Liu, Xinyong ^a   de Clercq, Erik ^c  

^a SHANDONG UNIVERSITY   (China)

^b CHONGQING THREE GORGES UNIVERSITY   (China)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral activity; HIV 1; Synthesis; Thiadiazole; Thioacetanilides

Indexed keywords

2 (5 (NAPHTHALEN 1 YL) 1,2,3 THIADIAZOL 4 YLTHIO) N ACETAMIDE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DELAVIRDINE; N (2 BROMOPHENYL) 2 (5 (NAPHTHALEN 1 YL) 1,2,3 THIADIAZOL 4 YLTHIO)ACETAMIDE; N(2 CHLOROPYRIDIN 3 YL) 2 (5 (NAPHTHALEN 1 YL) 1,2,3 THIADIAZOL 4 YLTHIO)ACETAMIDE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84865095081     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. De Clercq, E. (2004) Int. J. Biochem. Cell Biol. 36: 1800-22.
2. De Clercq, E. (2005) J. Med. Chem. 48: 1297-313.
3. De Clercq, E. (2007) Nat. Rev. Drug Discov. 6: 1001-18.
4. Wang, Z., B. Wu, K.L. Kuhen, B. Bursulaya, T.N. Nguyen, D.G. Nguyen et al. (2006) Bioorg. Med. Chem. Lett. 16: 4174-7.
5. Zhao, H & Z.Guo (2009) Drug Discov. Today. 14: 516-22.
6. Zhan, P., X. Liu, Y. Cao, Y. Wang, & E. De Clercq (2008) Bioorg. Med. Chem. Lett. 18: 5368-71.
7. Zhan, P., X. Liu, Z. Fang, Z. Li, C. Pannecouque & E. De Clercq (2009) Eur. J. Med. Chem. 44:4648-53.
8. Zhan, P., X. Liu, Z. Li, Z. Fang, C. Pannecouque & E. De Clercq (2010) Chem. Biodivers. 7: 1717-27.
9. Zhan, P., X. Liu, J. Zhu, Z. Fang, Z. Li, C. Pannecouque et al. (2009) Bioorg. Med. Chem. 17: 5775-81.
10. Zhan, P., X. Liu, Z. Fang, C. Pannecouque & E. De Clercq (2009) Bioorg. Med. Chem. 17: 6374-79.
11. Zhan, P., X. Chen, X. Li, D. Li, Y. Tian, W. Chen et al. (2011) Eur J Med Chem. 46: 5039-45.
12. Zhan, P., X. Liu, J. Zhu, Z. Fang, Z. Li, C.D. Pannecouque et al. (2009) Bioorg. Med. Chem. 17: 5920-27.
13. Lima, L. M & E. J. Barreiro (2005) Curr. Med. Chem. 12: 23-49.
14. Patani, G. A & E. J. LaVoie (1996) Chem. Rev. 96: 3147-76.
15. Olesen, P. H (2001) Curr. Opin. Drug Discov. Devel. 4: 471-8.
16. Pannecouque, C., D. Daelemans & E. De Clercq (2008) Nat Protoc. 3: 427-34.
17. Popovic, M., M.G. Sarngadharan, E. Read & R.C. Gallo (1984) Science. 224: 497-500.
18. Barrè-Sinoussi, F., J. C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret, J. Grest et al. (1983) Science. 220: 868-71.
19. Miyoshi, I., H. Taguchi, I. Kobonishi, S. Yoshimoto, Y. Ohtsuki, Y. Shiraishi et al. (1982) 28: 219-28.
20. Lee, V.J., W.V. Curran, T.F. Fields & K. Learn (1988) Heterocycl. Chem. 25: 1873-91.